251 related articles for article (PubMed ID: 12444101)
1. Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate.
Sun CX; Haipek C; Scoles DR; Pulst SM; Giovannini M; Komada M; Gutmann DH
Hum Mol Genet; 2002 Dec; 11(25):3167-78. PubMed ID: 12444101
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling.
Scoles DR; Nguyen VD; Qin Y; Sun CX; Morrison H; Gutmann DH; Pulst SM
Hum Mol Genet; 2002 Dec; 11(25):3179-89. PubMed ID: 12444102
[TBL] [Abstract][Full Text] [Related]
3. The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the "open" conformation and suppresses cell growth and motility.
Gutmann DH; Haipek CA; Burke SP; Sun CX; Scoles DR; Pulst SM
Hum Mol Genet; 2001 Apr; 10(8):825-34. PubMed ID: 11285248
[TBL] [Abstract][Full Text] [Related]
4. The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate.
Scoles DR; Huynh DP; Chen MS; Burke SP; Gutmann DH; Pulst SM
Hum Mol Genet; 2000 Jul; 9(11):1567-74. PubMed ID: 10861283
[TBL] [Abstract][Full Text] [Related]
5. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.
Rong R; Surace EI; Haipek CA; Gutmann DH; Ye K
Oncogene; 2004 Nov; 23(52):8447-54. PubMed ID: 15378014
[TBL] [Abstract][Full Text] [Related]
6. Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.
Kimura Y; Saya H; Nakao M
Neuropathology; 2000 Sep; 20(3):153-60. PubMed ID: 11132929
[TBL] [Abstract][Full Text] [Related]
7. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
Surace EI; Haipek CA; Gutmann DH
Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of neurofibromatosis 2 (NF2) missense mutations.
Gutmann DH; Hirbe AC; Haipek CA
Hum Mol Genet; 2001 Jul; 10(14):1519-29. PubMed ID: 11448944
[TBL] [Abstract][Full Text] [Related]
9. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
[TBL] [Abstract][Full Text] [Related]
10. HRS inhibits EGF receptor signaling in the RT4 rat schwannoma cell line.
Scoles DR; Qin Y; Nguyen V; Gutmann DH; Pulst SM
Biochem Biophys Res Commun; 2005 Sep; 335(2):385-92. PubMed ID: 16083858
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.
Stokowski RP; Cox DR
Am J Hum Genet; 2000 Mar; 66(3):873-91. PubMed ID: 10712203
[TBL] [Abstract][Full Text] [Related]
12. Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.
Lepont P; Stickney JT; Foster LA; Meng JJ; Hennigan RF; Ip W
Mutat Res; 2008 Jan; 637(1-2):142-51. PubMed ID: 17868749
[TBL] [Abstract][Full Text] [Related]
13. Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1.
Kissil JL; Wilker EW; Johnson KC; Eckman MS; Yaffe MB; Jacks T
Mol Cell; 2003 Oct; 12(4):841-9. PubMed ID: 14580336
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.
Rong R; Tang X; Gutmann DH; Ye K
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18200-5. PubMed ID: 15598747
[TBL] [Abstract][Full Text] [Related]
15. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
[TBL] [Abstract][Full Text] [Related]
16. The tumour suppressor protein NF2/merlin: the puzzle continues.
Hovens CM; Kaye AH
J Clin Neurosci; 2001 Jan; 8(1):4-7. PubMed ID: 11148074
[TBL] [Abstract][Full Text] [Related]
17. Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function.
Yang C; Asthagiri AR; Iyer RR; Lu J; Xu DS; Ksendzovsky A; Brady RO; Zhuang Z; Lonser RR
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4980-5. PubMed ID: 21383154
[TBL] [Abstract][Full Text] [Related]
18. VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation.
Huang J; Chen J
Oncogene; 2008 Jul; 27(29):4056-64. PubMed ID: 18332868
[TBL] [Abstract][Full Text] [Related]
19. Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.
Wong HK; Shimizu A; Kirkpatrick ND; Garkavtsev I; Chan AW; di Tomaso E; Klagsbrun M; Jain RK
Neoplasia; 2012 Feb; 14(2):84-94. PubMed ID: 22431917
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
Grönholm M; Teesalu T; Tyynelä J; Piltti K; Böhling T; Wartiovaara K; Vaheri A; Carpén O
Mol Cell Neurosci; 2005 Apr; 28(4):683-93. PubMed ID: 15797715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]